The mammalian gut ecosystem has considerable influence on host physiology [1] [2] [3] [4] , but the mechanisms that sustain this complex environment in the face of different stresses remain obscure. Perturbations to the gut ecosystem, such as through antibiotic treatment or diet, are at present interpreted at the level of bacterial phylogeny [5] [6] [7] . Less is known about the contributions of the abundant population of phages to this ecological network. Here we explore the phageome as a potential genetic reservoir for bacterial adaptation by sequencing murine faecal phage populations following antibiotic perturbation. We show that antibiotic treatment leads to the enrichment of phageencoded genes that confer resistance via disparate mechanisms to the administered drug, as well as genes that confer resistance to antibiotics unrelated to the administered drug, and we demonstrate experimentally that phages from treated mice provide aerobically cultured naive microbiota with increased resistance. Systems-wide analyses uncovered post-treatment phage-encoded processes related to host colonization and growth adaptation, indicating that the phageome becomes broadly enriched for functionally beneficial genes under stress-related conditions. We also show that antibiotic treatment expands the interactions between phage and bacterial species, leading to a more highly connected phage-bacterial network for gene exchange. Our work implicates the phageome in the emergence of multidrug resistance, and indicates that the adaptive capacity of the phageome may represent a community-based mechanism for protecting the gut microflora, preserving its functional robustness during antibiotic stress.
Antibiotic treatment, an important and often necessary therapeutic intervention, can negatively affect the mammalian gut environment, potentially giving rise to immune 2 and metabolic deficiencies 8 . Studies on the disruption of intestinal homeostasis have focused on the resulting alterations in microbial composition 6, 7 . However, investigation of the gut ecosystem has uncovered a myriad of resident phages 9 , and it remains unclear how perturbation of the gut environment affects these symbionts. Phages can contribute genes that are advantageous to their microbial hosts 10, 11 , in turn promoting their own survival and propagation 12 . This gene flow suggests that phages may have an important role in the adaptation of the microbiome to stressful environments. We used a comparative metagenomic approach to explore the effects of antibiotic perturbation on functions encoded in the phageome, as well as to examine how antibiotic treatment alters the phage-bacterial ecological network.
We treated groups of young adult mice (n 5 5) orally with physiologically relevant concentrations of ciprofloxacin (a quinolone that inhibits DNA synthesis) or ampicillin (a b-lactam that inhibits cellwall synthesis), each with a respective control. We obtained collective faecal samples from each group after 8 weeks of treatment and purified phages as previously described 9, 13 . DNA was extracted from phages and whole-genome amplified before performing shotgun 454 GS FLX1 pyrosequencing. We obtained a total of 440,792 quality reads, with a median read length of 477 nucleotides (210 megabases in total; Supplementary Fig. 1 ). Evaluation of contamination by quantification of bacterial 16S ribosomal RNA genes indicated that contaminating bacterial sequences represented less than 0.1% of our data, which was subsequently accounted for in all statistical analyses (see Supplementary Discussion and Supplementary Fig. 2 ).
Phage DNA sequences were compared to the non-redundant National Center for Biotechnology Information (NCBI) protein and environmental protein databases (BLASTX; E value ,10 25 ). Approximately 70% of reads were not assigned to previously sequenced genes (Supplementary Fig. 3 ), suggesting that the mouse phageome, like many other viral communities 14, 15 , harbours uncharacterized genetic material. We used the most significant BLAST alignment of a sequence, when available, to determine its phylogenetic origin. Most of the identifiable phages in our mouse phageomes ( Supplementary Fig. 4a ) were from the Caudovirales order, comprising the tailed phage families Siphoviridae, Podoviridae and Myoviridae, many of which are known to have a temperate life cycle. Because phage genomes incorporate bacterial genes, we also identified bacterial taxa; we found that 97% of phageencoded bacterial genes were attributable to the four phyla known to dominate the gut (Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria; Supplementary Fig. 4b ), consistent with the known hosts of the phages we detected.
We wondered whether antibiotic treatment leads to increases in phage-encoded genes for drug resistance. To investigate this, we compared DNA sequences in the phageome to an assembled database of antibiotic-resistance proteins (BLASTX; E value ,10 23 , see Methods). We found that reads annotated as antibiotic-resistance genes were highly enriched in phage metagenomes from mice treated with ciprofloxacin or ampicillin compared with those from control mice (Z score 5 7.3 and Z 5 7.0, respectively; Supplementary Fig. 5 ; read annotations enumerated in Supplementary Table 1 ). We catalogued the resistance reservoir by annotating phage-encoded genes based on the drug class to which they confer resistance ( Fig. 1a ). Our analysis revealed that resistance to the administered drug class was enriched in phage metagenomes from antibiotic-treated mice, such that resistance to DNAsynthesis inhibitors was enriched in ciprofloxacin treatment (Z 5 2.6), and resistance to cell-wall-synthesis inhibitors was enriched in ampicillin treatment (Z 5 5.0). Additionally, upon drug treatment, new resistance genes were found in the phageome. For example, phages from ciprofloxacin-treated mice carried genes encoding numerous quinolone efflux pumps (for example, norM, mexD, mexF), and phages from ampicillin-treated mice carried genes encoding sensor and response regulators of cell-wall-synthesis inhibitors (for example, vanRS).
Of note, resistance to other, orthogonal drug classes was also overrepresented in the antibiotic-perturbed phageomes. Both treatments led to significant enrichment of resistance to antibiotics that target protein synthesis, and ciprofloxacin treatment also led to significant enrichment of resistance to cell-wall synthesis inhibitors (Fig. 1a) . This cross-resistance was mediated by drug-specific inactivators (for example, chloramphenicol acetyltransferases), as well as multidrug-resistance exporters (for example, mdtK; Supplementary Table 1 ). Together, these findings implicate the phage metagenome as a potential source of multidrug resistance during antibiotic treatment of the host.
We aimed to understand the specific mechanisms represented in phage-encoded genes conferring resistance to the most significantly enriched classes of antibiotics: inhibitors of cell-wall synthesis, DNA synthesis, and protein synthesis. We categorized resistance genes according to primary resistance mechanisms, which include modification or protection of the drug target (target modification), enzymatic inactivation of the drug (drug inactivation), and transport of the drug out of the cell (efflux) 16 . Using this framework to classify phage-encoded resistance genes, our analysis revealed that antibiotic treatment led to disparate resistance mechanism profiles for each drug class ( Fig. 1b ). Analysis of resistance to cell-wall-synthesis inhibitors showed that all types of resistance mechanisms were significantly enriched with both ciprofloxacin treatment and ampicillin treatment. By contrast, resistance to DNAsynthesis and protein-synthesis inhibitors occurred predominantly by efflux. Resistance to protein-synthesis inhibitors occurred by target modification and drug inactivation mechanisms at low levels and, in accordance with its rarity, resistance to DNA-synthesis inhibitors through drug inactivation was not detected. These data probably reflect resistance mechanisms that are both environmentally available in the gut ecosystem and impose sustainable in vivo fitness costs. As continued treatment with an antibiotic invariably leads to its own resistance, mechanisms that enable cross-resistance encoded by the phageome may be an important consideration when selecting subsequent therapeutics.
We next sought to demonstrate that phages from antibiotic-treated mice confer increased drug resistance to the host-associated bacterial community. We assessed the frequency of resistant isolates from aerobically cultured naive microbiota that were infected ex vivo with phages from antibiotic-treated or control (untreated) mice. Our results show that this fraction of microbiota infected with phages from mice administered ciprofloxacin or ampicillin yielded two to three times more colonies resistant to the respective drug than the aerobically cultured fraction of microbiota infected with phages from control mice (Fig. 1c) . These data indicate that phages from antibiotic-treated mice can contribute relevant functional advantages to their microbial hosts.
We next took a systems-level approach and classified other phageencoded genes into functional pathways described by the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. We depicted enriched functional changes in phage metagenomes after antibiotic treatment as a network diagram ( Fig. 2 ; abundances shown in Supplementary Fig. 6 ). Among the most significantly enriched pathways were functional properties related to the mode of action of the administered drug (Supplementary Table 2 ). Phageomes from ampicillin-treated mice were enriched for the amino sugar and nucleotide metabolism pathway (part of the broader carbohydrate metabolism process; Z 5 5.6), indicating overrepresentation of genes related to synthesis of cell-wall constituents, and increases in these components have been shown to be requisite for drug resistance in clinical isolates 17 . Additionally, we found that phageomes from ciprofloxacin-treated mice were enriched for replicationand repair-related pathways, including base excision repair (Z 5 6.1), nucleotide excision repair (Z 5 7.4) and homologous recombination (Z 5 11.2). Included in these pathways are members of the GO system for the repair of DNA oxidative lesions, which has been demonstrated to reduce cytotoxicity due to a range of antibiotic classes 18 . Also represented are members of the DNA-damage-inducible SOS system, known to provide protection against antibiotic-mediated cell death and induce the development of resistance-conferring mutations 19 . Furthermore, hyper-recombination has been shown to promote multidrug resistance phenotypes 20 . These results show that under drug treatment, the phageome encodes diverse mechanisms for modulating antibiotic susceptibility.
We also observed that phage metagenomes from antibiotic-treated mice were enriched for microbial functions that contribute to host metabolism ( Fig. 2 and Supplementary Table 2 ). Phageomes from ciprofloxacintreated mice were uniquely enriched for pathways relevant to the metabolism of cofactors and vitamins, including thiamine, an essential nutrient provided by the microbiome. Microbiota ferment polysaccharides indigestible by the host alone; metabolism of these sugars enables bacterial survival in and colonization of the gut environment 21 and, as a beneficial consequence, provides energy to the host 4 . We found that polysaccharide-degradation genes, specifically related to metabolism of starch, cellulose, lactose and fructans (plant-derived fructose polymers), were enriched with antibiotic treatment (Fig. 3a) . Genes coding for carbohydrate active enzymes (CAZymes), which enable bacteria to ferment a variety of dietary-and host-sourced glycans, were also enriched with antibiotic treatment and were represented by a range of glycoside hydrolase and glycosyltransferase families (Supplementary Fig. 7 and Supplementary Table 3 ). Because many gut microbes express only a specific array of carbohydrate-degrading enzymes 22 , bacteria that acquire these genes from the phage reservoir may gain additional foraging capacity and, consequently, a selective growth advantage. These results suggest that the phageome may be an adaptive repository for functions important for the host-commensal relationship that may otherwise be depleted by antibiotic perturbation. (See Supplementary Information for additional discussion.)
We next aimed to elucidate the phylogenetic basis of these phageencoded bacterial functions. In Fig. 3b , we illustrate the taxonomic composition of all sequences of bacterial origin and sequences annotated with enriched functions following drug perturbation. Examining bacterial phylotypes that contribute antibiotic-resistance genes to the phage metagenome, we found a comparatively high representation of the Clostridia class and a low representation of the Bacilli class. 
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Notably, a large fraction of CAZyme-annotated sequences originated from the Bacteroidetes class, which comprises members found to have diverse capabilities for carbohydrate metabolism 22 . Investigation of thiamine metabolism reveals that the Bacilli and Verrucomicrobia classes constitute a large proportion of these annotations. As the phageome reflects emergent properties of its environment 15 , phylogenetic analyses of phage-encoded elements may more broadly enable the identification of bacteria actively contributing to specific functions in the gut environment.
Our results show that the phageome harbours a diversity of potentially beneficial functional elements in the face of antibiotic perturbation. However, the extent to which this genetic reservoir is accessible to members of the microbiota remains unclear 23 . To investigate this, we sought to elucidate the phage-bacterial ecological network and how it changes under antibiotic treatment. We approximated the network of phage-microbe interactions with relationships identified through the reconstruction and analysis of individual viral genomes. De novo assembly was accomplished using stringent parameters (see Methods). Reconstructed viral genomes are composed of a mosaic of bacterial genes, and we used the phylogenetic origins of these sequences to determine putative phage-bacterial associations (Fig. 4 ). Our resulting network recapitulated known interactions, including the lysogenic relationships of foodborne pathogens, such as bacteriophage Q3626 infection of Clostridium perfringens 24 and Siphoviridae Listeria phage A500 infection of Listeria monocytogenes 25 . Importantly, antibiotic treatment leads to widespread restructuring of the phage-bacterial ecological network (Fig. 4) . These data show that new links between phages and bacteria are formed with drug treatment, giving rise to significantly greater network connectivity ( Supplementary Fig. 8 ). This increased connectivity is reflective of phages broadly, as more bacterial species are associated with a given phage ( Supplementary  Fig. 9 ). These results suggest that antibiotic treatment increases the frequency of phage integration and stimulates broad host range, which promotes a functional reservoir that is both genetically diverse and highly accessible to gut bacteria.
Although the phageome is a highly connected network for gene exchange, the functional consequence of acquiring genetic material from this reservoir depends on the molecular context of the host bacterium. Acquisition of a single gene may enhance an existing function by gene dosage or enable a novel phenotype. As some proteins rely on additional machinery, subsequent horizontal gene-transfer events may be required to produce a phenotype. Moreover, redundantly acquired genes may gain new functionality through paralogueous evolution.
We demonstrate that antibiotic treatment enriches the phage metagenome for stress-specific and niche-specific functions, while mediating changes in the topology of the phage-bacterial ecological network to potentiate accessibility of these genetic elements. Functional resilience of the microbiome following environmental perturbation has been empirically documented and has engendered interest in the restorative forces that return the commensal flora to its pre-perturbed state 6, 7, 26 . Our results implicate phage encapsulation of adaptive signatures as a community-based mechanism for functional robustness in the gut environment during stress. Of note, antibiotic treatment can also prime the gut environment for pathogen invasion 2 , and our findings have potential implications for the emergence of drug resistance and evasion strategies in pathogenic populations. Cohabitation of phages and bacteria in the gut ecosystem is probably governed by complex and dynamic interactions, particularly during stress perturbation. Additional work is needed to discern the selective pressures imposed on each member of this community and the resulting mechanisms that influence the a, Bacterial enzymes from sugar metabolism to glycolysis (left) with corresponding Z scores in phages from drug-treated mice in comparison with control mice (right). Dashed line corresponds to a Z score of 1.65 (P 5 0.05). b, Class-level taxonomic distribution of all sequences of bacterial origin identified in phage sequencing data (far left) and sequences annotated with enriched functions following drug perturbation. 'Other' constitutes taxa that contributed less than 1% to all distributions.
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encoding and progressive enrichment of functionally beneficial genes in the phageome. Phage-mediated gene flow may be an important phenotypic buffer for bacterial communities, and further investigation of the adaptive reservoir of the phageome and the dynamic nature of the phage-bacterial ecological network may prove critical to understanding the influence of the gut ecosystem on host physiology.
METHODS SUMMARY
Groups of 6-week-old female FVB mice were treated with antibiotics in their drinking water to achieve doses of 28.5 mg kg 21 day 21 ampicillin or 12.5 mg kg 21 day 21 ciprofloxacin. Control groups were supplied with standard drinking water (ampicillin) or alkaline water (ciprofloxacin). After 8 weeks, we harvested collective faecal samples from each group. Viral purification from faecal samples was performed as previously described 9, 13 . DNA was extracted from each viral sample and whole-genome amplified in three separate reactions. Equimolar concentrations of multiplexed samples were pooled on a single plate for 454 GS FLX1 pyrosequencing. To analyse sequencing reads, an antibiotic resistance database was assembled using sequences from the Antibiotic Resistance Genes Database (ARDB) 27 and UniProt proteins were annotated with the Gene Ontology term ''antibiotic breakdown''. Custom perl scripts were written to annotate sequences with KEGG (v.61.0). Enrichment between treatment and control was calculated by random sampling with replacement (n 5 10,000), and Z scores were computed from the resulting normal distribution. Contigs were assembled using the Roche 454 GS De novo Assembler with default parameters, except for a minimum overlap of 100 bp and a minimum identity of 100%. associations between virotypes and bacterial species identified from phylogenetic analysis of reconstructed phage genomes. Phage-bacterial associations only in control metagenomes (black), only in drug-treated metagenomes (red), and commonly identified in control and drug-treated metagenomes (grey). Data are the union of associations identified in 50 assemblies of randomly sampled reads from each treatment.
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